Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy

References

• Federation ID. IDF diabetes atlas. 7th ed. Brussels: International Diabetes Federation; 2014.
   Google Scholar
• Hood DG. Continuous subcutaneous insulin infusion for managing diabetes: women’s health implications. Nurs Womens Health. 2012;16(4):308–318.
   PubMedGoogle Scholar
• Misso ML, Egberts KJ, Page M, et al. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD005103.
   PubMedGoogle Scholar
• Morling JR, Balkau B, Wild SH. Diabetes in women: a life-course approach. Menopause Int. 2013;19(2):87–95.
   PubMedGoogle Scholar
• Maahs DM, West NA, Lawrence JM, et al. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481–497.
   PubMed Web of Science ®Google Scholar
• Goldner WS, Kraus VL, Sivitz WI, et al. Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther. 2004;6(4):473–480.
   PubMedGoogle Scholar
• Barata DS, Adan LF, Netto EM, et al. The effect of the menstrual cycle on glucose control in women with type 1 diabetes evaluated using a continuous glucose monitoring system. Diabetes Care. 2013;36(5):e70.
   Google Scholar
• Keely E, Barbour LA. Management of diabetes in pregnancy. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Source: Endotext. South Dartmouth (MA): MDText.com, Inc; 2000-. 2014 Feb 14.
   Google Scholar
• Mathiesen JM, Secher AL, Ringholm L, et al. Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes. J Matern Fetal Neonatal Med. 2014;27(7):724–728.
   PubMed Web of Science ®Google Scholar
• Ringholm L, Mathiesen ER, Kelstrup L, et al. Managing type 1 diabetes mellitus in pregnancy–from planning to breastfeeding. Nat Rev Endocrinol. 2012;8(11):659–667.
   PubMed Web of Science ®Google Scholar
• Stenhouse E. Effects of diabetes on women’s reproductive health. Nurs Stand. 2012;26(38):35–40.
   PubMedGoogle Scholar
• Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003;111(5 Pt 1):933–938.
   PubMed Web of Science ®Google Scholar
• Giannini C, Mohn A, Chiarelli F. Technology and the issue of cost/benefit in diabetes. Diabetes Metab Res Rev. 2009;25 Suppl 1:S34–S44.
   Google Scholar
• Gregg EW, Zhuo X, Cheng YJ, et al. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study. Lancet Diabetes Endocrinol. 2014;2(11):867–874.
   PubMed Web of Science ®Google Scholar
• Huxley RR, Peters SA, Mishra GD, et al. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(3):198–206.
   PubMed Web of Science ®Google Scholar
• Hammond P, Liebl A, Grunder S. International survey of insulin pump users: impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life. Prim Care Diabetes. 2007;1(3):143–146.
   PubMedGoogle Scholar
• Golden SH, Sapir T. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. J Manag Care Pharm. 2012;18(6 Suppl):S1–S17.
   Google Scholar
• Weiss R, Garg SK, Bergenstal RM, et al. Predictors of hypoglycemia in the ASPIRE in-home study and effects of automatic suspension of insulin delivery. J Diabetes Sci Technol. 2015;9(5):1016–1020.
   PubMedGoogle Scholar
• Porcellati F, Lucidi P, Bolli GB, et al. Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. Diabetes Care. 2013;36(12):3860–3862.
   PubMed Web of Science ®Google Scholar
• Saboo BD, Talaviya PA. Continuous subcutaneous insulin infusion: practical issues. Indian J Endocrinol Metab. 2012;16(Suppl 2):S259–S262.
   Google Scholar
• Mukhopadhyay A, Farrell T, Fraser RB, et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and meta-analysis of randomized, controlled trials. Am J Obstet Gynecol. 2007;197(5):447–456.
   PubMed Web of Science ®Google Scholar
• Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry. Diabetes Care. 2015;38(6):971–978.
   PubMed Web of Science ®Google Scholar
• Johnson SR, Cooper MN, Jones TW, et al. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56(11):2392–2400.
   PubMed Web of Science ®Google Scholar
• Gabbe SG, Carpenter LB, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol. 2007;50(4):1014–1024.
   PubMed Web of Science ®Google Scholar
• Stage E, Norgard H, Damm P, et al. Long-term breast-feeding in women with type 1 diabetes. Diabetes Care. 2006;29(4):771–774.
   PubMed Web of Science ®Google Scholar
• Riviello C, Mello G, Jovanovic LG. Breastfeeding and the basal insulin requirement in type 1 diabetic women. Endocr Pract. 2009;15(3):187–193.
   PubMed Web of Science ®Google Scholar
• Catalano PM, McIntyre HD, Cruickshank JK, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780–786.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. New Engl J Med. 2008;358(19):1991–2002.
   PubMed Web of Science ®Google Scholar
• Gabbe SG, Holing E, Temple P, et al. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol. 2000;182(6):1283–1291.
   PubMed Web of Science ®Google Scholar
• Combs CA. Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy. J Matern Fetal Neonatal Med. 2012;25(10):2025–2027.
   PubMed Web of Science ®Google Scholar
• Lapolla A, Dalfra MG, Masin M, et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol. 2003;40(3):143–149.
   PubMed Web of Science ®Google Scholar
• Roeder HA, Moore TR, Ramos GA. Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus. Am J Obstet Gynecol. 2012;207(4):324.e1–324.e5.
   PubMed Web of Science ®Google Scholar
• Bruttomesso D, Bonomo M, Costa S, et al. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). Diabetes Metab. 2011;37(5):426–431.
   PubMed Web of Science ®Google Scholar
• Kallas-Koeman MM, Kong JM, Klinke JA, et al. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia. 2014;57(4):681–689.
   PubMed Web of Science ®Google Scholar
• Ringholm L, Secher AL, Pedersen-Bjergaard U, et al. The incidence of severe hypoglycaemia in pregnant women with type 1 diabetes mellitus can be reduced with unchanged HbA1c levels and pregnancy outcomes in a routine care setting. Diabetes Res Clin Pract. 2013;101(2):123–130.
   PubMed Web of Science ®Google Scholar
• Lambert K, Holt RI. The use of insulin analogues in pregnancy. Diabetes Obes Metab. 2013;15(10):888–900.
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007;30(4):771–776.
   PubMed Web of Science ®Google Scholar
• Hod M, Damm P, Kaaja R, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol. 2008;198(2):186.e1–186.e7.
   PubMed Web of Science ®Google Scholar
• Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet. 2015;292(4):749–756.
   PubMed Web of Science ®Google Scholar
• Murphy HR, Elleri D, Allen JM, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2012;55(2):282–293.
   PubMed Web of Science ®Google Scholar
• Goudie RJ, Lunn D, Hovorka R, et al. Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different. Diabetes Care. 2014;37(6):e121–e122.
   Google Scholar
• Davis SN, Horton ES, Battelino T, et al. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Diabetes Technol Ther. 2010;12(4):249–255.
   PubMed Web of Science ®Google Scholar
• Hirsch IB, Armstrong D, Bergenstal RM, et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther. 2008;10(4):232–244; quiz 245–246.
   Web of Science ®Google Scholar
• Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464–1476.
   PubMed Web of Science ®Google Scholar
• Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805.
   PubMed Web of Science ®Google Scholar
• Anderson J, Attvall S, Sternemalm L, et al. Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice. J Diabetes Sci Technol. 2011;5(6):1472–1479.
   PubMedGoogle Scholar
• Bailey T, Bode BW, Christiansen MP, et al. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17(11):787–794.
   PubMed Web of Science ®Google Scholar
• Widom B, Diamond MP, Simonson DC. Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care. 1992;15(2):213–220.
   PubMed Web of Science ®Google Scholar
• Trout KK, Rickels MR, Schutta MH, et al. Menstrual cycle effects on insulin sensitivity in women with type 1 diabetes: a pilot study. Diabetes Technol Ther. 2007;9(2):176–182.
   PubMed Web of Science ®Google Scholar
• Walsh CH, Malins JM. Menstruation and control of diabetes. Br Med J. 1977;2(6080):177–179.
   PubMed Web of Science ®Google Scholar
• Brown SA, Jiang B, McElwee-Malloy M, et al. Fluctuations of hyperglycemia and insulin sensitivity are linked to menstrual cycle phases in women with T1D. J Diabetes Sci Technol. 2015;9:1192–1199.
   PubMedGoogle Scholar
• Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol. 2009;5(10):553–558.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Schrott HG, Greendale G, et al. Factors associated with glucose and insulin levels in healthy postmenopausal women. Diabetes Care. 1996;19(4):333–340.
   PubMed Web of Science ®Google Scholar
• Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31(5):1060–1079.
   PubMed Web of Science ®Google Scholar
• Evers IM, ter Braak EW, de Valk HW, et al. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care. 2002;25(3):554–559.
   PubMed Web of Science ®Google Scholar
• Kerssen A, de Valk HW, Visser GH. The Continuous Glucose Monitoring System during pregnancy of women with type 1 diabetes mellitus: accuracy assessment. Diabetes Technol Ther. 2004;6(5):645–651.
   PubMedGoogle Scholar
• Secher AL, Stage E, Ringholm L, et al. Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with Type 1 diabetes - an observational study. Diabet Med. 2014;31(3):352–356.
   PubMed Web of Science ®Google Scholar
• Cordua S, Secher AL, Ringholm L, et al. Real-time continuous glucose monitoring during labour and delivery in women with Type 1 diabetes - observations from a randomized controlled trial. Diabet Med. 2013;30(11):1374–1381.
   PubMed Web of Science ®Google Scholar
• Murphy HR. Integrating educational and technological interventions to improve pregnancy outcomes in women with diabetes. Diabetes Obes Metab. 2010;12(2):97–104.
   PubMed Web of Science ®Google Scholar
• Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008;337:a1680.
   PubMed Web of Science ®Google Scholar
• Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013;36(7):1877–1883.
   PubMed Web of Science ®Google Scholar
• Rubin RR, Borgman SK, Sulik BT. Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy. Diabetes Educ. 2011;37 Suppl 1:5S–18S; quiz 19S–20S.
   PubMed Web of Science ®Google Scholar
• Raccah D, Sulmont V, Reznik Y, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009;32(12):2245–2250.
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–320.
   PubMed Web of Science ®Google Scholar
• Up close with Medtronic’s new MiniMed 640G system in Europe [Internet]. The diaTribe Foundation; 2015. [cited 2015 Nov 12]. Available from: http://diatribe.org/medtronics-new-minimed-640g-system-europe
   Google Scholar
• Olsen BS, Conget I, Vorrink L, et al. Performance of the predictive low glucose management feature of the MiniMed 640G system in a user evaluation study. American Diabetes Association 75th Scientific Sessions. Sunday General Poster Session, June 7, 2015. Boston, MA: American Diabetes Association; 2015.
   Google Scholar
• Petrovski G, Dimitrovski C, Bogoev M, et al. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technol Ther. 2011;13(11):1109–1113.
   PubMed Web of Science ®Google Scholar
• Murphy HR, Kumareswaran K, Elleri D, et al. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34(12):2527–2529.
   PubMed Web of Science ®Google Scholar
• Murphy HR, Elleri D, Allen JM, et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011;34(2):406–411.
   PubMed Web of Science ®Google Scholar
• Arrais RF, Dib SA. The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Hum Reprod. 2006;21(2):327–337.
   PubMed Web of Science ®Google Scholar
• Dorman JS, Steenkiste AR, Foley TP, et al. Menopause in type 1 diabetic women: is it premature? Diabetes. 2001;50(8):1857–1862.
   PubMed Web of Science ®Google Scholar
• Codner E, Merino PM, Tena-Sempere M. Female reproduction and type 1 diabetes: from mechanisms to clinical findings. Hum Reprod Update. 2012;18(5):568–585.
   PubMed Web of Science ®Google Scholar
• Matejko B, Cyganek K, Katra B, et al. Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients. Rev Diabet Stud. 2011;8(2):254–258.
   PubMedGoogle Scholar
• Rizvi AA, Petry R, Arnold MB, et al. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocr Pract. 2001;7(5):364–369.
   PubMedGoogle Scholar
• Hainer TA. Managing older adults with diabetes. J Am Acad Nurse Pract. 2006;18(7):309–317.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JM, Ormiston TM, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab. 2006;8(5):538–554.
   PubMed Web of Science ®Google Scholar
• Hunt CW, Sanderson BK, Ellison KJ. Support for diabetes using technology: a pilot study to improve self-management. Medsurg Nurs. 2014;23(4):231–237.
   PubMedGoogle Scholar
• Arsand E, Froisland DH, Skrovseth SO, et al. Mobile health applications to assist patients with diabetes: lessons learned and design implications. J Diabetes Sci Technol. 2012;6(5):1197–1206.
   PubMedGoogle Scholar
• Montori VM, Helgemoe PK, Guyatt GH, et al. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care. 2004;27(5):1088–1094.
   PubMed Web of Science ®Google Scholar
• Charpentier G, Benhamou P-Y, Dardari D, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34(3):533–539.
   PubMed Web of Science ®Google Scholar
• Franc S, Borot S, Ronsin O, et al. Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control? Diabetes Metab. 2014;40(1):61–66.
   PubMed Web of Science ®Google Scholar
• Chilelli NC, Dalfra MG, Lapolla A. The emerging role of telemedicine in managing glycemic control and psychobehavioral aspects of pregnancy complicated by diabetes. Int J Telemed Appl. 2014;2014:621384.
   PubMedGoogle Scholar
• Holmes VA, Spence M, McCance DR, et al. Evaluation of a DVD for women with diabetes: impact on knowledge and attitudes to preconception care. Diabet Med. 2012;29(7):950–956.
   PubMed Web of Science ®Google Scholar
• Sparud-Lundin C, Ranerup A, Berg M. Internet use, needs and expectations of web-based information and communication in childbearing women with type 1 diabetes. BMC Med Inform Decis Mak. 2011;11:49.
   PubMed Web of Science ®Google Scholar
• Berg M, Adolfsson A, Ranerup A, et al. Person-centered web support to women with type 1 diabetes in pregnancy and early motherhood–the development process. Diabetes Technol Ther. 2013;15(1):20–25.
   PubMed Web of Science ®Google Scholar
• Adolfsson A, Linden K, Sparud-Lundin C, et al. A web-based support for pregnant women and new mothers with type 1 diabetes mellitus in Sweden (MODIAB-Web): study protocol for a randomized controlled trial. Trials. 2014;15(1):513.
   PubMed Web of Science ®Google Scholar